Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.80M | 6.60M | -397.30M | 4.30M | 1.80M |
| Total Depreciation and Amortization | 10.00M | 9.60M | 11.10M | 11.70M | 11.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.40M | 4.10M | 399.10M | 3.30M | 6.40M |
| Change in Net Operating Assets | -6.80M | 5.40M | 45.00M | 3.70M | 8.30M |
| Cash from Operations | 6.80M | 25.70M | 57.90M | 23.00M | 27.80M |
| Capital Expenditure | -11.00M | -6.70M | -4.80M | -3.00M | -5.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 2.10M | -2.10M |
| Other Investing Activities | -2.20M | -2.40M | -2.80M | -11.10M | 2.10M |
| Cash from Investing | -13.20M | -9.10M | -7.60M | -12.00M | -5.90M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -2.40M | -27.30M | -27.30M | -13.20M | -1.50M |
| Issuance of Common Stock | 0.00 | 400.00K | 0.00 | 600.00K | 0.00 |
| Repurchase of Common Stock | -800.00K | -2.20M | -100.00K | -100.00K | -3.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -3.30M | 0.00 |
| Cash from Financing | -3.20M | -29.10M | -27.40M | -16.00M | -5.00M |
| Foreign Exchange rate Adjustments | 2.90M | 1.80M | -4.20M | 1.80M | -500.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.70M | -10.70M | 18.70M | -3.20M | 16.40M |